Characterization of the amidoxime reducing components ARC1 and ARC2 from Arabidopsis thaliana

Ludmila Maiber,Anna Koprivova,Daniel Bender,Stanislav Kopriva,Katrin Fischer‐Schrader
DOI: https://doi.org/10.1111/febs.16450
2022-04-11
Abstract:Five molybdenum‐dependent enzymes are known in eukaryotes. While four of them are under investigation since decades, the most recently discovered, (mitochondrial) amidoxime reducing component ((m)ARC), has only been characterized in mammals and the green algae Chlamydomonas reinhardtii. While mammalian mARCs have been shown to be involved in various signaling pathways, Chlamydomonas ARC was shown to be a nitric oxide (NO)‐forming nitrite reductase. Similar to mammals, higher plants possess two ARC proteins. In order to test whether plant ARCs have a similar function in NO production to the function they have in C. reinhardtii, we analyzed the enzymes from the model plant Arabidopsis thaliana. Both ARC1 and ARC2 from Arabidopsis could reduce N‐hydroxylated compounds, while nitrite reduction to form NO could only be demonstrated for ARC2. Searching for physiological electron donors we found that both ARC enzymes accept electrons from NADH via cytochrome b5 reductase and cytochrome b5, but only ARC2 is able to accept electrons from nitrate reductase. Furthermore, arc‐deficient mutant plants were similar to wildtype plants regarding growth and also nitrite‐dependent NO‐formation. Altogether, our results did not confirm the hypothesis that either ARC1 or ARC2 are involved in physiologically relevant nitrite‐dependent NO‐formation. In contrast, our data suggest that ARC1 and ARC2 have distinct, yet unknown physiological roles in higher plants.
What problem does this paper attempt to address?